TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Predict S.P.A. Class B ( (IT:PRE) ) has issued an update.
Predict S.p.A.’s Board of Directors has approved the adoption of the ‘Organization, Management and Control Model’ pursuant to Legislative Decree 231/2001, along with appointing a Supervisory Body to ensure compliance and updates. This move, following Predict’s recent listing on Euronext Growth Milan, aims to enhance corporate governance, transparency, and stakeholder protection, aligning with the company’s commitment to high standards and best practices.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the healthcare sector, focusing on in vivo diagnostics through ultrasound and radiological equipment, breath analysis technologies, and digital healthcare solutions. The company operates through four Strategic Business Units, offering products like Mistral for non-invasive oncological screening, Aphel for robotic support in healthcare, and Optip for remote medical consultations and training. Predict has established partnerships with leading Italian university hospitals and research institutes.
YTD Price Performance: -25.07%
Average Trading Volume: 8,875
Technical Sentiment Consensus Rating: Strong Buy
See more insights into PRE stock on TipRanks’ Stock Analysis page.